Hemodialysis Vascular Grafts Market By Raw Material (Polyurethane, Polyester, Polytetrafluoroethylene and Biological Material) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The hemodialysis vascular grafts market is set to reach from US$ 196.6 Mn in 2017 to US$ 285.2 Mn by 2026 representing balanced growth at a compounded annual growth rate (CAGR) of 4.3% during the forecast period from 2018 to 2026. Atrial fibrillation is the most common type of cardiac arrhythmia diagnosed globally. According to the research findings brought forward by World Health Organization (WHO), the number of end stage renal disease patients worldwide receiving dialysis will be approximately 5.24 million by 2030. The common causes associated with morbidity during hemodialysis are infection, hemorrhage and vascular grafts rejection. Synthetic materials are being made with a blend of polymers to achieve the desired materials strength, adhesion, durability and pliability. Bioengineered materials will be the latest trendsetter due to advantages associated with it such as negligible graft rejection and excellent biocompatibility.

Market Synopsis 

Hemodialysis Vascular Grafts Market

Get a sample copy for more information

"Excellent adhesion, native fistula pliability and reimbursement scenario drive the polytetrafluoroethylene raw material market growth"

Polytetrafluoroethylene is leading the raw material segment for hemodialysis vascular grafts market. The primary features which are responsible for the dominance of polytetrafluoroethylene as a vascular graft are outstanding adhesion properties, native fistula pliability and reimbursement scenario. High dielectic strength and low coeeficent of friction ensures smooth and painless hemodialysis procedure in patients suffering with chronic kidney disease.  Polyurethane holds the second largest market owing to positive attributes such as its material strength and ability to provide thinner inner wall as a vascular graft thereby providing larger inner luminal diameter to provide excellent blood flow during hemodialysis procedure. Biological raw material will be the fastest growing segment during the forecast period owing to less infection rate, low hemorrhage and excellent biocompatibility. They are made from human saphenous veins and other bioengineered material. 

Hemodialysis Vascular Grafts Market

Get a sample copy for more information

"Increasing geriatric population suffering with chronic kidney disease and increased healthcare expenditure drive the market growth in North America"

North America is presently holding 36% share in the regional segment for hemodialysis vascular grafts market. As per the research study conducted by Center for Disease Control and Prevention (CDC) in 2016, approximately 4.9 million United States citizens were reported to be diagnosed with kidney disease. The drivers that promote the market growth in North America region are increasing healthcare expenditure and rising geriatric population suffering with chronic kidney disease. Existence of major players such as C.R.Bard, Inc., Terumo Medical Corporation and W.L.Gore & Associates etc. further propel the market growth in North America region. Europe holds the second largest market with 28% share owing to the supportive regulatory environment provided by European Medical Agency (EMA) and increasing demand for hemodialysis in comparison to peritoneal dialysis. Asia Pacific represents 20% market share and is to register excellent during in the near future on account of increasing prevalence of renal disorders and proactive government policies to counteract kidney complications.

Hemodialysis Vascular Grafts Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026. 

Hemodialysis Vascular Grafts Market

Report Scope by Segments

The market is segmented by raw material and by geography.

Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million

 By Raw Material (2016–2026; US$ Mn)
 • Polyurethane
 • Polyester
 • Polytetrafluoroethylene
 • Biological Material

 Geography Segment (2016–2026; US$ Mn)
 • North America (United States and Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Pharmaceutical companies manufacturing hemodialysis vascular grafts are C.R.Bard, Inc., CryoLife, Inc., Getinge AB., InnAVasc Medical, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., Proteon Therapeutics, Inc., Terumo Medical Corporation, Vascular Genesis and W.L.Gore Associates.

Key questions answered in this report

  • What are the latest market trends prevalent in the hemodialysis vascular grafts market?
  • What will be the market size and CAGR during the forecast period from 2018 to 2026
  • What is the hemodialysis and its benefits in patients suffering with end stage renal disease?
  • Which pharmaceutical companies are engaged in the production of hemodialysis vascular grafts?
  • What are the advantages associated with raw materials such as polytetrafluoroethylene and polyurethane?
  • Why is North America the largest regional segment in hemodialysis vascular grafts market?
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Published Date:  Feb 2019
Category:  Medical Devices
Report ID:   59569
Report Format:   PDF
Pages:   120
Rating:    4.2 (66)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support